Recruitment

Recruitment Status
Completed
Estimated Enrollment
2000

Inclusion Criteria

Age 20 and more
Agreed with written informed consent form
Intervention with Promus PREMIER everolimus eluting coronary stent
Age 20 and more
Agreed with written informed consent form
Intervention with Promus PREMIER everolimus eluting coronary stent

Exclusion Criteria

Intervention with Promus PREMIER everolimus eluting coronary stent and other drug eluting stent at the same time
Life expectancy of 1year and under
Cardiac shock
Intervention with Promus PREMIER everolimus eluting coronary stent and other drug eluting stent at the same time
Life expectancy of 1year and under
Cardiac shock

Summary

Conditions
  • Coronary (Artery) Disease
  • Coronary Disease
  • Heart Diseases
  • Myocardial Ischemia
  • Coronary Artery Disease
Type
Observational
Design
  • Observational Model: Cohort
  • Time Perspective: Prospective

Participation Requirements

Age
Between 20 years and 125 years
Gender
Both males and females

Inclusion Criteria

Age 20 and more
Agreed with written informed consent form
Intervention with Promus PREMIER everolimus eluting coronary stent
Age 20 and more
Agreed with written informed consent form
Intervention with Promus PREMIER everolimus eluting coronary stent

Exclusion Criteria

Intervention with Promus PREMIER everolimus eluting coronary stent and other drug eluting stent at the same time
Life expectancy of 1year and under
Cardiac shock
Intervention with Promus PREMIER everolimus eluting coronary stent and other drug eluting stent at the same time
Life expectancy of 1year and under
Cardiac shock

Tracking Information

NCT #
NCT02060968
Collaborators
  • CardioVascular Research Foundation, Korea
  • Boston Scientific Korea Co. Ltd
Investigators
Not Provided